Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04073394 · ClinicalTrials.gov registry record · NA
Individualized Lifestyle Intervention for Obesity Management Based on Obesity Phenotypes
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 215
- Enrollment target
NCT04073394: Completed NA study, sponsored by Mayo Clinic.
NCT04073394 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 215 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04073394, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 215 participants
- Enrollment target
Study Summary
The purpose of this protocol is to define an "individualized diet" approach based on obesity related phenotypes (pathophysiology obesity classification), which would increase weight loss, adherence, and weight loss maintenance.
Primary Outcome
Change in body weight during the 12 week study
Interventions
- BEHAVIORAL Standard Lifestyle Intervention
- BEHAVIORAL Modified Lifestyle Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 215 participants |
| Start Date | 2020-07-06 |
| Est. Completion | 2022-01-31 |
| Phase | NA |
What the finished NCT04073394 record still lists
NCT04073394 is an interventional study that assigns participants to a tested intervention. The registered 215 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard Lifestyle Intervention is the first listed.
NCT04073394 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04073394 about?
NCT04073394 is a clinical study titled "Individualized Lifestyle Intervention for Obesity Management Based on Obesity Phenotypes". The purpose of this protocol is to define an "individualized diet" approach based on obesity related phenotypes (pathophysiology obesity classification), which would increase weight loss, adherence, and weight loss maintenance.
What is the current status of trial NCT04073394?
This trial is currently completed. It is a NA study. The enrollment target is 215 participants. The study started on 2020-07-06. Estimated completion is 2022-01-31.
What interventions are being tested in trial NCT04073394?
The interventions under investigation include: Standard Lifestyle Intervention (BEHAVIORAL), Modified Lifestyle Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04073394?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04073394's enrollment target sits among peer trials
215 487th of 2000 higher than 1,514 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05134012 · 215 participants · Phase 3
RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW)
- NCT05169970 · 215 participants · Phase 2
A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer
- NCT05197270 · 215 participants · Phase 1
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- NCT05230199 · 215 participants · NA
Sensory Optimization of the Hospital Environment
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI